Concepedia

Up‐regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma

Wei Cao, Zhien Feng, Zhibin Cui, Chenping Zhang, Zhaoyao Sun, Li Mao, Wantao Chen

Cancer · 2011 · 66 citations · 34 references

DOIFull text

Open access

Abstract

The current results indicated that EZH2 is an independent prognostic indicator for patients with HNSCC. In addition, an analysis of the combined expression of EZH2 and cyclin D1 can serve as a more powerful prognostic predictor for patients with HNSCC.

References

34

Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing

Ru Cao, Liangjun Wang, Hengbin Wang et al. · Science · 2002 · 3.7K citations

, , +17

The polycomb group protein EZH2 is involved in progression of prostate cancer

Sooryanarayana Varambally, Saravana M. Dhanasekaran, Ming Zhou et al. · Nature · 2002 · 2.7K citations · Full text

, , +8

The Polycomb group protein EZH2 directly controls DNA methylation

Emmanuelle Viré, Carmen Brenner, Rachel Deplus et al. · Nature · 2005 · 2.2K citations

, , +7

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

Yutaka Kondo, Lanlan Shen, Alfred S.L. Cheng et al. · Nature Genetics · 2008 · 604 citations

, , +12

Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer

Stéphane Temam, Hidetoshi Kawaguchi, Adel K. El‐Naggar et al. · Journal of Clinical Oncology · 2007 · 399 citations · Full text